Insider Transactions Reported by 11 Insiders of Iterum Therapeutics plc

Symbol
ITRM on Nasdaq
Location
Dublin 1, Ireland

Insiders trading volume in the past year

Iterum Therapeutics plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
RONALD HUNT Director $483K 13 Jan 2025
Corey N. Fishman Chief Executive Officer, Director $192K 06 Aug 2024
Michael W. Dunne Director $88K +$13K +17.4% 18 Nov 2025
Beth Hecht Director $26.4K 15 Jun 2023
Mark Chin Director $25.6K 15 Jun 2023
Sailaja Puttagunta Chief Medical Officer $14.5K 01 Dec 2023
Christine Coyne Chief Commercial Officer 01 Jul 2025
Brenton K. Ahrens Director 23 Dec 2022
David G. Kelly Director 15 Jun 2022
Judith M. Matthews Chief Financial Officer 31 Mar 2023
Joseph J. Whalen Director 10 Mar 2025

Recent Insider Transactions by Companies or Individuals for Iterum Therapeutics plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.